Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, August 30, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Lyxumia® One-Step Regimen as Effective as Two-Step Regimen in Improving Glycemic Control in Type 2 Diabetes
Tuesday, September 13, 2011
New phase III data from GetGoal-F1 study of once-daily Lixisenatide support simplified treatment initiation.

Puracyp and Promega Combine Cell Line and Assay Systems for Complete Solution for Drug Developers
Friday, September 02, 2011
Companies teamed up to provide all-inclusive kits to assess nuclear receptor activation, P450 metabolism, and cellular toxicity.

Roche Launches Cedex Bio Bioprocess Analyzer for Reliable Metabolite Profiling and Substrate Analysis in Biotherapeutics Manufacturing
Friday, September 02, 2011
Cedex Bio Bioprocess Analyzer enables safe and reliable determination of chemical and biochemical parameters in aqueous solutions.

Agilent Technologies Offers Grants for Research in Integrated Biology
Thursday, July 21, 2011
Agilent Technologies Inc. announces that it is accepting entries for two systems biology research grants, both intended to spur development of open source data-integration tools.

Metanomics Health Launches its Energy Metabolite Platform - a Unique Target Platform Based on Metabolite Profiling
Friday, July 08, 2011
The targeted platform maps key metabolites affecting the energy status of a biological system.

Metabolons Vitamin D Deficiency Test Now Available for Patient Analysis
Thursday, July 07, 2011
Tandem mass spectrometry test run in Company’s CLIA registered laboratory.

Thermo Fisher Scientific Announces Breakthrough Workflow for Metabolomics Research
Tuesday, June 28, 2011
A new generation of application software with cutting-edge Orbitrap LC-MS technology advances metabolomics research.

New Q-TOF LC/MS Offers 10 Times More Sensitivity
Wednesday, June 15, 2011
Agilent Technologies, Inc. introduces the 6550 iFunnel quadrupole time-of-flight liquid chromatography mass spectrometry (Q-TOF LC/MS) system. It increases TOF sensitivity to low femtogram levels while delivering fast acquisition to 50 spectra/sec, up to five orders of intra-scan dynamic range, and robust performance and operation.

Thermo Scientific Launches New GC-MS/MS Instrument for Superior Selectivity and Sensitivity at ASMS 2011
Wednesday, June 08, 2011
New triple quadrupole gas chromatography-mass spectrometry system designed to offer best-in-class selectivity, analytical performance and productivity.

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 331
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv